ETON - Financial Reports List - Eton Pharmaceuticals, Inc. - IntrinsicAlpha

Eton Pharmaceuticals, Inc. ETON

Healthcare - Biotechnology - NASDAQ - US

$ 20.38

3.27 %

$ 547 M

Market Cap

-112.44

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	116.95%	-93.83%	41.25%
Quarterly Report	Q4	8-K	2024-12-31	59.26%	73.49%	131.58%
Annual Report	FY	10-K	2024-12-31	23.29%	-308.44%	-117.87%
Quarterly Report	Q3	8-K	2024-09-30	46.90%	208.29%	192.88%
Quarterly Report	Q2	8-K	2024-06-30	-24.36%	-66.70%	-75.59%
Quarterly Report	Q1	8-K	2024-03-31	50.19%	72.15%	68.43%
Quarterly Report	Q4	8-K	2023-12-31	-13.94%	-247.37%	-245.93%
Annual Report	FY	10-K	2023-12-31	48.90%	90.43%	85.57%
Quarterly Report	Q3	8-K	2023-09-30	118.33%	81.88%	81.07%
Quarterly Report	Q2	8-K	2023-06-30	63.05%	392.62%	389.78%

1